View Item 

Show simple item record

Beneficios obtenidos con la inmunización antisarampionosa

dc.contributor.authorAxnick, Norman Wes_ES
dc.contributor.authorShavell, Steven Mes_ES
dc.contributor.authorWitte, John Jes_ES
dc.date.accessioned2015
dc.date.available2015
dc.date.issueds.d.es_ES
dc.date.issued1970es_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/14507
dc.description.abstractThe immunization effort against measles in the United States was initiated in 1963. It has resulted in a sharp decrease in incidence of the disease -from 4 million cases in 1963 to one quarter of a million cases in 1968- and in associated costsen_US
dc.description.abstractA study by researchers of the National Communicable Disease Center shows that during the year 1963 through 1968 the immunization effort is estimated to have averted 9.7 million acute cases of measles and 3,244 cases of mental retardation. It also is estimated to have saved 973 lives, 555,000 hospital days, 291,000 years of normal life, more than 1.6 million workdays, 32 million schooldays, and $423 millionen_US
dc.description.abstractAbout nine-tenths of the savings in each of these categories has been realized in the last 3 years -the period of intensive national effort to eradicate measles(AU)en_US
dc.description.abstractPublicado en inglés en el Public Health Rep 84 (8): 673-680, 1969en_US
dc.relation.ispartofseriesBoletín de la Oficina Sanitaria Panamericana (OSP);68(3),mar. 1970es_ES
dc.subjectSarampoes_ES
dc.subjectSarampoes_ES
dc.subjectInquéritos Epidemiológicoses_ES
dc.subjectControle de Doenças Transmissíveispt_BR
dc.subjectEstados Unidoses_ES
dc.titleBeneficios obtenidos con la inmunización antisarampionosaes_ES
dc.title.alternativeBenefits due to immunization against measleses_ES
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US


Files in this item

Thumbnail
Name:
v68n3p201.pdf
Size:
797.6Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record